ArticleTherapeutic advances in urology2017

Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies.

Andrea Tubaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.